Seoul National University

Korea Food Research Institute

Advanced Protein Technologies Corporation

Catholic Kwandong University Industry Foundation

Young-Wook Chin

Jin-Ho Seo

Hae-Yong Jo

Hyo Jin Kim

Sung Jin Moon

Hae Won Jang

Woo Kyung Kang

Provided are a functional food or pharmaceutical composition or a method for preventing, alleviating or treating hyperphosphatemia and chronic kidney disease and treating chronic kidney disease using the composition comprisingsp. KCCM 11826P having excellent phosphorus-absorbing ability.

Pharmaceutical composition and healthy food composition withsp. KCCM 11826P for preventing or treating hyperphosphatemia in chronic kidney disease

Provided is a method of producing 2'-fucosyllactose including culturing in a medium supplemented with lactose a recombinanttransformed to express &#x3b1;-1,2-fucosyltransferase, transformed to express GDP-D-mannose-4,6-dehydratase, transformed to express GDP-L-fucose synthase, and transformed to express lactose permease, wherein the recombinanthas phosphomannomutase and GTP-mannose-1-phosphate guanylyltransferase.

Method of producing 2'-fucosyllactose using recombinant

Disclosed are a recombinant() for producing fucosyllactose which is transformed to express &#x3b1;-1,2-fucosyltransferase, GDP-D-mannose-4,6-dehydratase (Gmd), GDP-L-fucose synthase (WcaG) and lactose permease (LacY), wherein thehas phosphomannomutase and GTP-mannose-1-phosphate guanylyltransferase, and a method for producing fucosyllactose using the same. According to the recombinantand the method for producing fucosyllactose according to the present invention, with use of a GRASstrain, which is safer than conventional, 2'-fucosyllactose can be produced at a high concentration while overcoming drawbacks of conventional methods associated with industrial inapplicability resulting from low production concentrations.

Corynebacterium glutamicum for use in producing 2'-fucosyllactose

Growing community of inventors

Seongnam-si, South Korea

Young-Wook Chin